Our lab specializes in engineering nanomaterials for delivery of therapeutics and vaccines, regenerative medicine, and stem cell engineering applications. Specifically, we aim to understand nanoparticle structure-property-function relationship to enhance their efficacy as gene delivery vectors and vaccine delivery vehicles, and develop scalable methods for synthesizing self-assembled nanoparticles with tight control over shape, size and surface properties. We also use biomaterials platforms to influence stem cell fate and function, improve efficiency of cell therapies, and promote functional tissue regeneration.

We build upon the strong collaborative focus here at Hopkins, with access to a network of top scientists and clinicians within medical, biological, and engineering disciplines. We are part of the Institute for NanoBioTechnology (INBT) and Department of Materials Science and Engineering located on the engineering campus, the Translational Tissue Engineering Center (TTEC) located on the medical campus, and the Whitaker Biomedical Engineering Institute between the two campuses. Our research has a strong translational focus, and we enjoy several key partnerships with industry collaborators.